TOPICAL TREATMENT OF CUTANEOUS LEISHMANIASIS

被引：90
|
作者：
ELON, J
LIVSHIN, R
EVENPAZ, Z
HAMBURGER, D
WEINRAUCH, L
机构：
[1] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,HADASSAH UNIV HOSP,IL-91010 JERUSALEM,ISRAEL
[2] TEVA PHARMACEUT IND LTD,JERUSALEM,ISRAEL
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1986年 / 87卷 / 02期
关键词：
D O I：
10.1111/1523-1747.ep12696697
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：284 / 288
页数：5
相关论文
共 50 条
  • [21] THE EFFICACY OF TOPICAL KETOCONAZOLE IN CUTANEOUS LEISHMANIASIS
    ABAHUSAIN, A
    ALKHAWAJAH, A
    ALGINDAN, Y
    JAIN, S
    LARBI, E
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (05) : P645 - P645
  • [22] Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate
    Faghihi, G
    Tavakoli-kia, R
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (01) : 13 - 16
  • [23] Erysipeloid cutaneous leishmaniasis: treatment with a new, topical, pure herbal extract
    Zerehsaz, F
    Beheshti, S
    Rezaian, GR
    Joubeh, S
    EUROPEAN JOURNAL OF DERMATOLOGY, 2003, 13 (02) : 145 - 148
  • [24] Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis
    Nahidi, Yalda
    Goyonlo, Vahid Mashayekhi
    Layegh, Pouran
    Taghavi, Faezeh
    Najafi, Mona Najaf
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (02) : 220 - 226
  • [25] Topical treatment of persistent cutaneous leishmaniasis with ethlanolic lipid amphotericin B
    Zvulunov, A
    Cagnano, E
    Frankenburg, S
    Barenholz, Y
    Vardy, D
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (06) : 567 - 569
  • [26] Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
    Neira, Laura Fernanda
    Mantilla, Julio Cesar
    Escobar, Patricia
    SCIENTIA PHARMACEUTICA, 2023, 91 (04)
  • [27] Conventional formulations and emerging delivery systems for the topical treatment of Cutaneous Leishmaniasis
    Espuelas, Socorro
    THERAPEUTIC DELIVERY, 2015, 6 (02) : 101 - 103
  • [28] Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    Jaafari, Mahmoud Reza
    Hatamipour, Mahdi
    Alavizadeh, Seyedeh Hoda
    Abbasi, Azam
    Saberi, Zahra
    Rafati, Sima
    Taslimi, Yasaman
    Mohammadi, Akram Miramin
    Khamesipour, Ali
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 11 : 156 - 165
  • [29] Efficient topical treatment for cutaneous leishmaniasis based on amphotericin B.
    Frankenburg, S
    Glick, D
    Klaus, S
    Barenholz, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 674 - 674
  • [30] Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
    Ben Salah, Afif
    Ben Messaoud, Nathalie
    Guedri, Evelyn
    Zaatour, Amor
    Ben Alaya, Nissaf
    Bettaieb, Jihene
    Gharbi, Adel
    Hamida, Nabil Belhadj
    Boukthir, Aicha
    Chlif, Sadok
    Abdelhamid, Kidar
    El Ahmadi, Zaher
    Louzir, Hechmi
    Mokni, Mourad
    Morizot, Gloria
    Buffet, Pierre
    Smith, Philip L.
    Kopydlowski, Karen M.
    Kreishman-Deitrick, Mara
    Smith, Kirsten S.
    Nielsen, Carl J.
    Ullman, Diane R.
    Norwood, Jeanne A.
    Thorne, George D.
    McCarthy, William F.
    Adams, Ryan C.
    Rice, Robert M.
    Tang, Douglas
    Berman, Jonathan
    Ransom, Janet
    Magill, Alan J.
    Grogl, Max
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06): : 524 - 532
12345